FDA, SAEC Release First Data on Adverse Events | GenomeWeb

NEW YORK (GenomeWeb News) — A collection of new data about the genetics associated with drug-induced serious skin rashes has been released by the US Food and Drug Administration and the International Serious Adverse Events Consortium.

The FDA said yesterday that the release of this genetic data about serious skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, associated with adverse drug reactions could be used to help predict which individuals will experience them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.